Aerosols

09/02/1978 - "It was concluded that this new way of administering the drug was effective in chronic asthma, and should allow most patients with chronic asthma who cannot use conventional pressurised aerosols efficiently to benefit from inhaled corticosteroid treatment."
01/01/2004 - "Single doses of short-acting beta(2)-adrenoceptor agonists, given as aerosols immediately before exercise, are very effective in the majority of patients with asthma, providing about 80% protection for up to 2 hours. "
06/01/2005 - "The significant improvement in asthma control in patients receiving LAbeta2 suggests potential advantages for extrafine aerosols as part of anti-inflammatory treatment optimization."
08/01/1991 - "Inhalation of aerosols is the mainstay of treatment of asthma. "
11/01/1984 - "Since the 1950s, corticosteroid aerosols have proved useful in the treatment of asthma. "

03/01/1983 - "pneumophila itself; the etiology, pathogenesis, and epidemiology of infection; the mechanisms of immunity to infection; the role of aerosols and potable water in the transmission of disease; the spectrum of clinical manifestations; the efficacy of therapy; the features of sporadic cases; and the rapid diagnosis of infection by direct immunofluorescent techniques and bacteriologic methods. "
10/01/1990 - "These studies suggest that surfactant agents may make IFN aerosols much more effective for the prophylaxis of respiratory virus infections."
10/01/2008 - "This study aimed to quantify the blood content of aerosols produced during dental, maxillofacial and autopsy procedures and to identify those activities which involve the greatest risk of infection due to exposure to blood-containing aerosols. "
12/01/2007 - "Many-year studies on aerosols as an infection vector, despite their wide range, ignored dental aerosol. "
09/01/1988 - "[Development of a procedure for the study of the viral infection potential of dental aerosols]."

01/01/2004 - "[Written information on the use of aerosols in COPD patients. "
10/01/2003 - "Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease."
01/01/1995 - "In respect to effect/side effect relationship, more frequent administration of smaller doses may be the best method for administering beta 2-agonists as aerosols in patients with COAD. "
01/01/1993 - "The data suggest that exposure to organic aerosols in industrial settings, particularly in conjunction with smoking, may be associated with the development of chronic obstructive lung disease."
05/01/1992 - "Our data suggest that exposure to organic aerosols may contribute to the development of chronic obstructive lung disease."

01/01/2012 - "These results provide a better understanding of the exposure of workers to cough aerosols from patients and of the relative efficacy of different types of respiratory PPE, and they will assist investigators in providing research-based recommendations for effective respiratory protection strategies in health care settings."
11/01/1980 - "Although respiratory and mucociliary function have generally been found to remain unaltered or to deteriorate after administration of bland or mucolytic aerosols, some investigators have observed facilitated expectoration or improved cough efficiency. "
07/01/2008 - "The studies using hypertonic aerosols as the cough stimulant have suggested an enhanced sensitivity in asthmatic subjects but the induced bronchoconstriction has made the interpretation of the results difficult. "
03/01/2004 - "Quantification of viable cough-generated aerosols is feasible and offers a new approach to study infectiousness and transmission of M. "
03/01/2004 - "Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness."

09/01/1995 - "Studies with antibiotic aerosols as adjunct to intravenous therapy in cystic fibrosis patients with an acute exacerbation showed no enhancement of the clinical effects of the intravenous antibiotic by the aerosol; sputum colony counts, however, were lower. "
01/01/2015 - "Cystic fibrosis (CF) patients can be considered as high caries risk patients because they frequently consume sugar-rich food between meals and they have a high intake of sugar containing syrups, aerosols, and salivary flow reducing medication. "
01/01/2004 - "Cystic Fibrosis (CF) patients can hypothetically be considered as being high caries risk patients; they frequently consume sugar-rich in-between-meal snacks/drinks and they have a high intake of sugar containing syrups and aerosols (also acidic) and salivary flow reducing medication (beta-2-adrenergica). "
12/05/2002 - "Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy."
08/01/2001 - "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis."